Ovarian and Breast Cancer Risks Associated With Pathogenic Variants in <i>RAD51C</i> and <i>RAD51D</i>Xin Yang, Mark E. Robson, Dieter Niederacher et al.|JNCI Journal of the National Cancer Institute|2020Cited by 163
Individuals with FANCM biallelic mutations do not develop Fanconi anemia, but show risk for breast cancer, chemotherapy toxicity and may display chromosome fragilityIrene Catucci, Paolo Peterlongo, Ana Osório et al.|Genetics in Medicine|2017Cited by 93
Case-control analysis of truncating mutations in DNA damage response genes connects TEX15 and FANCD2 with hereditary breast cancer susceptibilityTuomo Mantere, Katri Pylkäs, Anna Tervasmäki et al.|Scientific Reports|2017Cited by 37
FANCM mutation c.5791C>T is a risk factor for triple-negative breast cancer in the Finnish populationJohanna I. Kiiski, Heli Nevanlinna, Anna Tervasmäki et al.|Breast Cancer Research and Treatment|2017Cited by 37